comparemela.com

Latest Breaking News On - Swiss official gazette - Page 7 : comparemela.com

SOPHiA GENETICS : To the shareholders of SOPHiA GENETICS SA (the Company) - Form 6-K

To the shareholders of SOPHiA GENETICS SA Invitation to the Annual General Meeting Date and Time: Monday, June 26, 2023, at 8:00 a.m. EDT / 2:00 p.m. CEST . | May 17, 2023

Saint sulpiceSwitzerland generalNew yorkUnited statesCity ofUnited kingdomMilton silva craigKathy hibbsDidier hirschLila tretikovTroy coxGabriel cottierJean michel cossJurgi camblongVincent ossipowComputershare trust company na

Takeover of Credit Suisse by UBS – critical issues and remaining uncertainties under Swiss law

Guy Deillon and Dr Christian Schönfeld of Prager Dreifuss drill into the thorny Swiss legal issues inherent to the dramatic buyout of Credit Suisse by UBS.

Swiss confederationSwiss national bankOffice of the commercial registerCredit suisse group agSwiss financial market supervisory authorityCredit suisse groupCredit suisseFederal councilSuisse groupSwiss constitutionSwiss mergerSwiss merger actFederal officeSwiss official gazetteSwiss takeover boardAdditional equity capital

Basilea Pharmaceutica : Minutes_EN | MarketScreener

English translation of the German original minutes Minutes of the 22nd Annual General Meeting of Basilea Pharmaceutica Ltd , held on April. | May 4, 2023

Domenico scalaStevend skolskyDamian hellerCaroline cronMartin nicklassonThomas wernerPeter ulliDaniel anlikerDavid veitchLeonard kruimerYves ackermannAndrea schmutzMeeting of basilea pharmaceutica ltdPricewaterhousecoopers ltdAnnual general meetingBasilea pharmaceutica ltd

Geberit : Minutes of the 24th General Meeting of Geberit AG (829 KB)

MINUTES 24th Ordinary General Meeting of the shareholders of Geberit AG, held on 19 April 2023 at 4:30 p.m. . | May 1, 2023

Switzerland generalPatrick schleifferLuca eberleJasmin stadlerManfred johnChristian buhlAlbertm baehnyMartin baumRoman sidlerFelixr ehratThomas illiChristian leuteneggerLenz staehelinRapperswil jona notary officeCompensation committeeAndreas lange group executive board

Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first quarter 2023 - QUVIVIQ now the leading branded insomnia medicine in the commercial market in the US

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - April 25, 2023 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2023. Commercial highlights QUVIVIQ

United statesSwitzerland generalUnited kingdomGreat britainMesse baselNeurocrine biosciencesAndrewc weissSchweizerisches handelsamtsblattSimon joseJean paul clozelHead of investor relations corporate communicationsRegulatory agencyCompany annualMochida pharmaceutical co ltdIdorsia ltdDay center

vimarsana © 2020. All Rights Reserved.